Die bikuspide Aortenklappe

Standard

Die bikuspide Aortenklappe. / Hillebrand, M.; Bernhardt, A.; Aydin, A.; Blankenberg, S.; Willems, S.; Von Kodolitsch, Y.; Lorenzen, Victoria.

In: Medizinische Welt, Vol. 64, No. 2, 2013, p. 106-109.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Hillebrand, M, Bernhardt, A, Aydin, A, Blankenberg, S, Willems, S, Von Kodolitsch, Y & Lorenzen, V 2013, 'Die bikuspide Aortenklappe', Medizinische Welt, vol. 64, no. 2, pp. 106-109.

APA

Hillebrand, M., Bernhardt, A., Aydin, A., Blankenberg, S., Willems, S., Von Kodolitsch, Y., & Lorenzen, V. (2013). Die bikuspide Aortenklappe. Medizinische Welt, 64(2), 106-109.

Vancouver

Hillebrand M, Bernhardt A, Aydin A, Blankenberg S, Willems S, Von Kodolitsch Y et al. Die bikuspide Aortenklappe. Medizinische Welt. 2013;64(2):106-109.

Bibtex

@article{766e335890724de284368382a8d4dc28,
title = "Die bikuspide Aortenklappe",
abstract = "Bicuspid aortic valve disease (BAV) is one of the most frequent congenital heart defects, and can be associated with other cardiovascular lesions. The most common complication is an associated valvular dysfunction consisting of aortic stenosis, aortic regurgitation, or infective endocarditis. Furthermore, it can lead to dilation of the ascending aorta with the potential complication of aortic dissection. Histopathological alterations such as cystic media necrosis with loss of smooth muscle cells indicate that BAV may be a systemic disease. Cardiologic imaging modalities such as echocardiography and MRI or CT of the aorta are necessary for timely detection of cardiovascular complications, and for timing of prophylactic aortic surgery. Further clinical studies are substantial for better understanding of the disease and to define optimal timing for interventions. This article focuses on current clinical guidelines, summarizes the pathophysiological and genetic basis of BAV, and outlines therapeutic strategies.",
keywords = "Aortic dilation, Aortic regurgitation, Aortic valve stenosis, Bicuspid aortic valve",
author = "M. Hillebrand and A. Bernhardt and A. Aydin and S. Blankenberg and S. Willems and {Von Kodolitsch}, Y. and Victoria Lorenzen",
year = "2013",
language = "Deutsch",
volume = "64",
pages = "106--109",
journal = "MED WELT",
issn = "0025-8512",
publisher = "Schattauer",
number = "2",

}

RIS

TY - JOUR

T1 - Die bikuspide Aortenklappe

AU - Hillebrand, M.

AU - Bernhardt, A.

AU - Aydin, A.

AU - Blankenberg, S.

AU - Willems, S.

AU - Von Kodolitsch, Y.

AU - Lorenzen, Victoria

PY - 2013

Y1 - 2013

N2 - Bicuspid aortic valve disease (BAV) is one of the most frequent congenital heart defects, and can be associated with other cardiovascular lesions. The most common complication is an associated valvular dysfunction consisting of aortic stenosis, aortic regurgitation, or infective endocarditis. Furthermore, it can lead to dilation of the ascending aorta with the potential complication of aortic dissection. Histopathological alterations such as cystic media necrosis with loss of smooth muscle cells indicate that BAV may be a systemic disease. Cardiologic imaging modalities such as echocardiography and MRI or CT of the aorta are necessary for timely detection of cardiovascular complications, and for timing of prophylactic aortic surgery. Further clinical studies are substantial for better understanding of the disease and to define optimal timing for interventions. This article focuses on current clinical guidelines, summarizes the pathophysiological and genetic basis of BAV, and outlines therapeutic strategies.

AB - Bicuspid aortic valve disease (BAV) is one of the most frequent congenital heart defects, and can be associated with other cardiovascular lesions. The most common complication is an associated valvular dysfunction consisting of aortic stenosis, aortic regurgitation, or infective endocarditis. Furthermore, it can lead to dilation of the ascending aorta with the potential complication of aortic dissection. Histopathological alterations such as cystic media necrosis with loss of smooth muscle cells indicate that BAV may be a systemic disease. Cardiologic imaging modalities such as echocardiography and MRI or CT of the aorta are necessary for timely detection of cardiovascular complications, and for timing of prophylactic aortic surgery. Further clinical studies are substantial for better understanding of the disease and to define optimal timing for interventions. This article focuses on current clinical guidelines, summarizes the pathophysiological and genetic basis of BAV, and outlines therapeutic strategies.

KW - Aortic dilation

KW - Aortic regurgitation

KW - Aortic valve stenosis

KW - Bicuspid aortic valve

UR - http://www.scopus.com/inward/record.url?scp=84877120792&partnerID=8YFLogxK

M3 - SCORING: Zeitschriftenaufsatz

AN - SCOPUS:84877120792

VL - 64

SP - 106

EP - 109

JO - MED WELT

JF - MED WELT

SN - 0025-8512

IS - 2

ER -